INS and Glucose intolerance: Long‐term rapamycin treatment leads to worsened glucose intolerance, lipid accumulation in the liver and β‐cell loss in diabetic animals.49, 50 Whether increased TFEB activation can rescue β‐cell loss and improve insulin sensitivity has yet to be explored.